from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3242c/-

LFCtreatmentdescriptionclass of inhibitor

0.329

Amikacinug/mL Amikacintranslation

-0.460

Cap5-10ug/mL Capreomycintranslation

-0.333

Rox10-50 ug/mL Roxithromycintranslation

0.190

SM2-5 ug/mL Streptomycintranslation

-0.127

Tet5-10 ug/mL Tetracyclinetranslation

0.391

Rif0.2-5ug/mL Rifampicintranscription

-0.483

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.511

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.825

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.304

CPZ10-50 ug/mL Chlorpromazinerespiration

1.830

Clofazimine10-13 ug/mL Clofaziminerespiration

0.440

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.445

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.218

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.482

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.189

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.074

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.293

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.359

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.691

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.471

KCN5-20 ug/mL Potassium cyaniderespiration

-0.584

NaN30.2-2 mM Sodium aziderespiration

-0.465

Nigericin50 uM Nigericinrespiration

0.381

TRC10-150 ug/mL Triclosanrespiration

-0.026

TRZ10-25 ug/mL Thioridazinerespiration

-0.625

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.420

menadione6-10 ug/mL Menadionerespiration

-0.202

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.353

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.119

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.961

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.711

NRP_1Non-replicating persistence stage 1dosRassociated

-0.189

Amp0.2mg/mL AmpicillincellWall

-0.055

Cephalexin20-100 ug/mL CephalexincellWall

-0.046

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.469

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.326

EMB10-20 ug/mL EthambutolcellWall

-0.337

Eta12-40 ug/mL EthionamidecellWall

-0.204

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.576

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.054

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.381

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.142

BZA0.12 mg/mL BenzamidearomaticAmides

-0.146

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.327

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.533

H2O24 mM hydrogen peroxideDNAdamaging

0.144

Levo10 ug/mL LevofloxacinDNAdamaging

0.235

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.046

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.668

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.396

UVUV-irradiationDNAdamaging

0.965

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.576

Antimycin12.5-50 ug/mL Antimycin A?

0.009

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.647

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.952

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.214

PA8240.2-2 ug/mL PA-824?

1.039

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.711

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.219

Verapamil50 uM Verapamil?

-0.426

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.769

methoxatin10-20 ug/mL Methoxatin?